Moving toward personalized medicine in the methadone maintenance treatment program: a pilot study on the evaluation of treatment responses in Taiwan.

Biomed Res Int · 2013 · PMC3876825 · PMID 24455721

Europe PMC DOI

hedged sentence

0.0200

closest p · 0.4× alpha

0.0200

boldest claim

The sentences

showed a trendP = 0.02actually significant

For ABCB1 C1236T, the T homozygous carriers (47.2 ± 24.7 mg) showed a trend towards a lower maintenance methadone dose than the T heterozygous carriers (50.4 ± 28.3 mg) and noncarriers (67.9 ± 50.4 mg) ( P = 0.02).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.